Presentation THT 2024 Early Feasibility Study of the Vivasure PerQseal® Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention Presenter: Rajiv Tayal March 04, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2023 Shelley Wood November 30, 2023
News Conference News ESC 2022 DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark L.A. McKeown August 30, 2022
News Daily News CV Complications of Malaria Rare but Portend Poor Prognosis Michael O'Riordan February 22, 2021
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2020 Shelley Wood November 30, 2020
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2019 Shelley Wood November 29, 2019
News Conference News VIVA 2019 Clinicians Get Real on Radiation: ‘Don’t Do Dumb Things’ L.A. McKeown November 07, 2019
News Conference News SCAI 2019 Paclitaxel DCBs and CHIP: SCAI Kicks Off With Two Hot-Potato Topics Yael L. Maxwell May 21, 2019
Presentation VIVA 2018 1-Year Outcomes for Eluvia in Long Lesions Presenter: William A. Gray November 09, 2018
News Daily News Vulnerable Plaque Components Seen on IVUS Not Linked With MACE, Two New Studies Show Michael O'Riordan October 17, 2018
News Conference News ACC 2018 My Takeaways From ACC 2018: Everyone Missing From Clinical Trials, Please Stand Up Shelley Wood March 27, 2018
News Daily News Hurricanes and Wildfires Take Their Toll on Prominent CVD Med-Tech Companies Todd Neale October 19, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2017 Shelley Wood September 30, 2017
Presentation VIVA 2017 What is the Right Antiplatelet Therapy for Symptomatic Carotid Disease? Presenter: William Gray September 21, 2017
Presentation VIVA 2017 Is Aspirin Really a Class I Medication in Peripheral Artery Disease? Presenter: Ehrin J. Armstrong September 19, 2017
Presentation VIVA 2017 Results from the IN.PACT SFA Randomized Trial Presenter: Peter A. Schneider September 15, 2017